Caribou Biosciences (CRBU) Amortizatization of Intangibles (2021 - 2026)
Caribou Biosciences (CRBU) reported Amortizatization of Intangibles of $269000.0 for Q1 2026, down 40.49% year-over-year from $452000.0 in Q1 2025, and up 68.12% on a QoQ basis from $160000.0 in Q4 2025.
Caribou Biosciences (CRBU) has 6 years of Amortizatization of Intangibles data on file, last reported at $269000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 40.49% year-over-year to $269000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $957000.0 (down 73.7% YoY) and the FY2025 annual result came in at $1.1 million, down 75.88% from the prior year.
- Amortizatization of Intangibles improved to $269000.0 in Q1 2026 per CRBU's latest filing, from $160000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.4 million in Q3 2023 and bottomed at -$1.6 million in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $452000.0 (2025), against an average of $668058.8.
- The widest annual swing landed in 2022, when Amortizatization of Intangibles soared 1836.54%; it then plunged 279.07% in 2023.
- Tracing CRBU's Amortizatization of Intangibles over 5 years: stood at $903000.0 in 2022, then sank by 279.07% to -$1.6 million in 2023, then jumped by 162.96% to $1.0 million in 2024, then slumped by 84.28% to $160000.0 in 2025, then surged by 68.12% to $269000.0 in 2026.
- Per Business Quant, the three latest CRBU Amortizatization of Intangibles figures stand at $269000.0 (Q1 2026), $160000.0 (Q4 2025), and $235000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | 269,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 269,000.00 |
| Mar 31, 2026 | 269,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 946,000.00 |
| Jun 30, 2024 | 946,000.00 |
| Mar 31, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 903,000.00 |
| Dec 31, 2022 | 903,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Jun 30, 2022 | -122,000.00 |
| Jun 30, 2022 | -122,000.00 |
| Mar 31, 2022 | -327,000.00 |
| Mar 31, 2022 | -327,000.00 |
| Dec 31, 2021 | -52,000.00 |
| Dec 31, 2021 | -52,000.00 |